Extracranial oral cavity metastasis from glioblastoma multiforme: A case report

  • Authors:
    • Philipp Günther Kup
    • Carsten Nieder
    • Guido Winnekendonk
    • Irenäus Anton Adamietz
    • Khashayar Fakhrian
  • View Affiliations

  • Published online on: August 12, 2016     https://doi.org/10.3892/mco.2016.991
  • Pages: 437-439
Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

Glioblastoma multiforme is the most common primary malignant brain tumor. The clinical outcome following diagnosis remains extremely poor. The treatment of choice is wide surgical resection of the visible tumor, frequently followed by adjuvant combined radiochemotherapy (RCTx) with temozolomide as the chemotherapeutic agent. Extracranial metastases are extremely rare, with <200 cases of extracranial metastases from glioblastoma multiforme reported in the literature to date. we herein present a case of a patient suffering from a fast‑growing metastasis to the oral cavity, completely filling the buccal cavity within 2 weeks, as the only manifestation of recurrent glioblastoma multiforme following initial surgical resection and adjuvant RCTx.

Introduction

Glioblastoma multiforme is a highly malignant glioma of astrocytic origin (1). The tumor is defined as grade IV according to the World Health Organization (WHO) classification, and is a cytologically malignant, mitotically active, necrosis-prone neoplasm, typically associated with rapid pre- and postoperative disease evolution and a fatal outcome, with a median survival of ~12 months (2,3).

With an incidence of 3.19/100.000 patient years, glioblastoma multiforme is the most common glioma in adults (typical age, 50–70 years), located mostly in the frontotemporal cerebral lobes (1,4).

The treatment of choice currently consists of maximal safe surgical resection and postoperative concomitant radiochemotherapy (RCTx), followed by further chemotherapy with the orally administered alkylating drug temozolomide (5). The indication for radiotherapy (RTx) depends on the patient's general condition [Karnofsky performance status (PS) or Eastern Cooperative Oncology Group PS], age and extent of surgery (6,7). Typically, conformal RTx consists of 54–60 Gy (1.8–2.0 Gy per fraction), with limited safety margins of a maximum 2.0 cm. Long-term local control is difficult to achieve. Extracranial metastases are reported to occur in 0.4–0.5% of all cases (812). In 1928, Davis first reported a patient with disseminated glioblastoma (13). The affected organs included the lung, upper extremity soft tissue and chest wall. The natural history of glioblastomas that metastasize to organs outside the central nervous system is largely unknown. Between 1928 and 2009, 88 cases of extracranial metastasis from glioblastoma (n=83) and gliosarcoma (n=5) have been published, reported and analyzed by Lun et al (14). In 2015, Pietschmann et al reviewed existing data and performed a new meta-analysis with 150 cases (15). In addition to brain stem and spinal axis, lymph nodes and visceral organs, including the liver, lung, pleura and bones, were found to be involved. In only one of all documented cases an extracranial oral cavity metastasis of significant extent and exhibiting rapid growth was described (16).

Case report

A 70-year-old female patient was admitted to our hospital suffering from progressive lack of concentration and cognitive deficit. The patient's husband also reported a personality change. Arterial hypertension, hyperthyroidism and lipometabolic disorder were documented, without other comorbidities. Initially, we performed magnetic resonance imaging (MRI) of the head, which revealed a massive tumor in the right frontal lobe, with perifocal oedema and midline dislocation of 6 mm, suspicious for glioblastoma (Fig. 1). The tumor was sized 4.2×2.8×3.9 cm. Navigated maximal safe tumor excision was performed with osteoplastic craniotomy and dura mater plastic surgery. The postoperative course was uneventful. Histology and immunohistochemical investigation revealed a O6-methylguanine-DNA methyltransferase-positive glioblastoma multiforme, WHO grade IV. Adjuvant RCTx was initially performed with low-dose temozolomide 140 mg/day, subsequently escalated to the standard dose of 200 mg/day (total dose 60 Gy, 2 Gy per fraction).

One year after the diagnosis, the patient developed a rapidly progressive oral cavity tumor, filling the entire buccal cavity within 2 weeks (Fig. 2). Following biopsy, the histological examination revealed a necrotic retromaxillary metastasis of the previously diagnosed glioblastoma, exhibiting histological characteristics identical to those of the primary resected tumor. Systemic metastases were not identified. The patient was unable to speak or eat (Fig. 3). Following extensive interdisciplinary discussion, we decided to proceed with local palliative RTx and supportive measures. The patient developed massive breathing difficulties, necessitating transfer to the intensive care unit, followed by tracheotomy and immediate mechanical ventilation. We first planned to administer a total of 45 Gy/3 Gy per fraction. In the light of rapid progress of the tumor, a dose of 5 Gy per fraction was applied (Fig. 3). However, after 4 applications, the patient's relatives requested discontinuation of RTx and the patient succumbed to the disease soon thereafter.

Discussion

We herein report the case of a patient suffering from glioblastoma with subsequent retromaxillary metastatic spread completely filling the buccal cavity. Initial treatment with cranial tumor extirpation followed by RCTx with 60 Gy and temozolomide was performed. At the time of relapse and clinical deterioration, the patient was treated with 20 Gy to the metastatic area. However, RTx was discontinued and the patient succumbed to the disease soon thereafter. Extracranial metastasis from glioblastoma remains an uncommon finding (15). Thus far, a massive metastasis completely filling the buccal cavity has only been reported in 1996 by Horiuchi et al (16) in a 41-year-old female. In contrast to our patient, simultaneous local recurrence of the tumor was described. MRI and computed tomography scans revealed orbital, nasal and oral masses extending inferiorly from the recurrent tumor in the right temporal lobe through the anterior and middle skull base. The oral cavity tumor and swelling of the patient's face grew rapidly. The common characteristics of the two cases are rapid growth and gender of the patient, but no connection to cranial tissue was radiologically detected in our patient.

The reasons for such extensive spread in this particular location and the growth rate are not well understood. A necessary requirement for extracranial metastasis is tumor cells crossing the dura mater, which is the most important barrier. Surgery and radiation therapy may lead to dural damage and potentially facilitate extracranial extension. In our case, no lesion of the dura mater was documented during surgery. A ventricular systemic shunt was not indicated. Our 70-year-old patient underwent craniotomy followed by RTx with simultaneous chemotherapy. Younger patients exhibit an increased risk of extraneural involvement due to prolonged survival (15,17). The most common sites of extracranial metastases from glioblastoma are the lungs, bone (bone marrow), lymph nodes and soft tissues (14). This is the second report of an extracranial metastasis with a retromaxillary localization, exhibiting rapid growth and completely filling the buccal cavity. Glioblastoma is a tumor with fatal outcome. Although extracranial metastases remain extremely uncommon, extraneural spread of the tumor is possible and must be considered in symptomatic patients during follow-up. Extracranial glioblastomas may present with an extraordinarily rapid progression pattern, as in our case. Therefore, fast decision-making and treatment initiation are crucial for optimal palliative treatment. Further investigation is required to improve therapy and outcome.

References

1 

Louis DN, Perry A, Burger P, Ellison DW, Reifenberger G, von Deimling A, Aldape K, Brat D, Collins VP, Eberhart C, et al: International Society Of Neuropathology - Haarlem: International Society of Neuropathology - Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol. 24:429–435. 2014. View Article : Google Scholar : PubMed/NCBI

2 

Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger G, et al: Long-term survival with glioblastoma multiforme. Brain. 130:2596–2606. 2007. View Article : Google Scholar : PubMed/NCBI

3 

Visser O, Ardanaz E, Botta L, Sant M, Tavilla A and Minicozzi P: EUROCARE-5 Working Group: Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study. Eur J Cancer. September 5–2015.(Epub ahead of print). doi: 10.1016/j.ejca.2015.07.032. View Article : Google Scholar

4 

DeAngelis LM: Brain tumors. N Engl J Med. 344:114–123. 2001. View Article : Google Scholar : PubMed/NCBI

5 

Preusser M, de Ribaupierre S, Wöhrer A, Erridge SC, Hegi M, Weller M and Stupp R: Current concepts and management of glioblastoma. Ann Neurol. 70:9–21. 2011. View Article : Google Scholar : PubMed/NCBI

6 

Dolecek TA, Propp JM, Stroup NE and Kruchko C: CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncol. 14(Suppl 5): 41–49. 2012. View Article : Google Scholar

7 

Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, Rohde V, Oppel F, Turowski B, Woiciechowsky C, et al: Extent of resection and survival in glioblastoma multiforme: Identification of and adjustment for bias. Neurosurgery. 62:564–576; discussion 564–576. 2008. View Article : Google Scholar : PubMed/NCBI

8 

Smith DR, Hardman JM and Earle KM: Metastasizing neuroectodermal tumors of the central nervous system. J Neurosurg. 31:50–58. 1969. View Article : Google Scholar : PubMed/NCBI

9 

Pasquier B, Pasquier D, N'golet A, Panh MH and Couderc P: Extraneural metastases of astrocytomas and glioblastomas: Clinicopathological study of two cases and review of literature. Cancer. 45:112–125. 1980. View Article : Google Scholar : PubMed/NCBI

10 

Astner ST, Pihusch R, Nieder C, Rachinger W, Lohner H, Tonn JC, Molls M and Grosu AL: Extensive local and systemic therapy in extraneural metastasized glioblastoma multiforme. Anticancer Res. 26:4917–4920. 2006.PubMed/NCBI

11 

Elena A, Melina C, Raffaele N, Carlo B, Vittoria N, Francesco A, Gaetano F and Marica E: Extraneural metastases in glioblastoma patients: Two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature. Neurosurg Rev. 39:37–46. 2016. View Article : Google Scholar : PubMed/NCBI

12 

Ray A, Manjila S, Hdeib AM, Radhakrishnan A, Nock CJ, Cohen ML and Sloan AE: Extracranial metastasis of glioblastoma: Three illustrative cases and current review of the molecular pathology and management strategies. Mol Clin Oncol. 3:479–486. 2015.PubMed/NCBI

13 

Davis L: Spongioblastoma multiforme of the brain. Ann Surg. 87:8–14. 1928.PubMed/NCBI

14 

Lun M, Lok E, Gautam S, Wu E and Wong ET: The natural history of extracranial metastasis from glioblastoma multiforme. J Neurooncol. 105:261–273. 2011. View Article : Google Scholar : PubMed/NCBI

15 

Pietschmann S, von Bueren AO, Kerber MJ, Baumert BG, Kortmann RD and Müller K: An individual patient data meta-analysis on characteristics, treatments and outcomes of glioblastoma/gliosarcoma patients with metastases outside of the central nervous system. PLoS One. 10:e01215922015. View Article : Google Scholar : PubMed/NCBI

16 

Horiuchi T, Osawa M, Itoh N, Kobayashi S, Nitta J and Hongo K: Extradural extension of glioblastoma multiforme into the oral cavity: Case report. Surg Neurol. 46:42–46. 1996. View Article : Google Scholar : PubMed/NCBI

17 

Bertolini F, Zunarelli E, Baraldi C, Valentini A, Del Giovane C, Depenni R, Falasca A, Giacobazzi P, Malagoli M, Meletti S, et al: Survival in patients with newly diagnosed conventional glioblastoma: A modified prognostic score based on a single-institution series. Tumori. 98:756–761. 2012.PubMed/NCBI

Related Articles

Journal Cover

October 2016
Volume 5 Issue 4

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Kup, P.G., Nieder, C., Winnekendonk, G., Adamietz, I.A., & Fakhrian, K. (2016). Extracranial oral cavity metastasis from glioblastoma multiforme: A case report. Molecular and Clinical Oncology, 5, 437-439. https://doi.org/10.3892/mco.2016.991
MLA
Kup, P. G., Nieder, C., Winnekendonk, G., Adamietz, I. A., Fakhrian, K."Extracranial oral cavity metastasis from glioblastoma multiforme: A case report". Molecular and Clinical Oncology 5.4 (2016): 437-439.
Chicago
Kup, P. G., Nieder, C., Winnekendonk, G., Adamietz, I. A., Fakhrian, K."Extracranial oral cavity metastasis from glioblastoma multiforme: A case report". Molecular and Clinical Oncology 5, no. 4 (2016): 437-439. https://doi.org/10.3892/mco.2016.991